Hereditary Angioedema — RACP Adult Medicine MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: B — Acquired C1-inhibitor deficiency
Hereditary angioedema type I is characterised by recurrent angioedema WITHOUT urticaria, low C4 (even between attacks – useful screening test), and low C1-inhibitor level and function. It is autosomal dominant. Acute attacks are treated with C1-inhibitor concentrate (Berinert), icatibant (bradykinin B2 receptor antagonist), or fresh frozen plasma. Long-term prophylaxis includes C1-inhibitor replacement, lanadelumab (anti-kallikrein), or berotralstat. Adrenaline and antihistamines are INEFFECTIVE as the mechanism is bradykinin-mediated, not histamine-mediated.
Reference: eTG – 2025 – Immunology; ASCIA – 2024 – HAE Guidelines